CLINICAL_TRIALS
withdrawal
· 2015-04-08
Clinical Trial Update: High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection [Phase 2]
Summary
A Phase 2 trial evaluating high-resolution microendoscopy to guide hysteroscopic tumor resection in uterine cancer has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Uterine Cancer | Phase 2 | Status: WITHDRAWN